Fulminant type 1 diabetes-an important subtype in East Asia

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 8, 2011, Pages 959-964

  Imagawa, Akihisa ^a   Hanafusa, Toshiaki ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Cytotoxic T lymphocyte antigen (CTLA) 4; Epidemiology; Human leukocyte antigen (HLA); Idiopathic; Virus

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA B ANTIGEN; HLA DR ANTIGEN; TOLL LIKE RECEPTOR 3; VIRUS ANTIBODY; VIRUS RNA;

ASIA; CELL INFILTRATION; COXSACKIE VIRUS; CYTOMEGALOVIRUS; ENTEROVIRUS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FULMINANT INSULIN DEPENDENT DIABETES MELLITUS; HEPATITIS A VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNE RESPONSE; IMMUNITY; INFLUENZA VIRUS B; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MUMPS VIRUS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

ACUTE DISEASE; ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; ENTEROVIRUS INFECTIONS; FAR EAST; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HLA-B ANTIGENS; HLA-DRB1 CHAINS; HUMANS; INSULIN-SECRETING CELLS; JAPAN; MALE; MIDDLE AGED; VIRUS DISEASES;

EID: 80855138381     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1236     Document Type: Review

References (32)

1. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000; 342(5): 301-307.
2. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Ann Med 2000; 32(8): 539-543.
3. Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 2003; 26(8): 2345-2352.
4. Hanafusa T, Imagawa A, Iwahashi H, et al. Report of Japan Diabetes Society Committee on fulminant type 1 diabetes mellitus research: epidemiological and clinical analysis and proposal of diagnostic criteria. J Japan Diab Soc 2005; 48(Suppl. 1): A1-A13 (Japanese).
5. Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab 2007; 3(1): 36-45.
6. Shimizu I, Makino H, Osawa H, et al. Association of fulminant type 1 diabetes with pregnancy. Diabetes Res Clin Pract 2003; 62(1): 33-38.
7. Shimizu I, Makino H, Imagawa A, et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab 2006; 91(2): 471-476.
8. Takaike H, Uchigata Y, Iwamoto Y, et al. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus. Ann Med 2008; 40(5): 395-400.
9. Murase Y, Imagawa A, Hanafusa T, et al. Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy-a nationwide 5-year-study in Japan. Diabetologia 2007; 50(3): 531-537.
10. Takeda H, Kawasaki E, Shimizu I, et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care 2002; 25(6): 995-1001.
11. Cho YM, Kim JT, Ko KS, et al. Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Diabetologia 2007; 50(11): 2276-2279.
12. Zheng C, Zhou Z, Zang C, et al. Prevalence, Clinical and Immunological Features of Fulminant Type 1 Diabetes Among Chinese Hunan Han Population. AASD2009 Abstract Book. The Asian Association for the Study of Diabetes and Japan Diabetes Society: Tokyo, Japan, 2009; 10.
13. Taniyama M, Katsumata R, Aoki K, Suzuki S. A Filipino patient with fulminant type 1 diabetes. Diabetes Care 2004; 27(3): 842-843.
14. Chiou CC, Chung WH, Hung SI, Yang LC, Hong HS. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol 2006; 54(2 Suppl.): S14-S17.
15. Moreau C, Drui D, Arnault-Ouary G, Charbonnel B, Chaillous L, Cariou B. Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab 2008; 34(5): 529-532.
16. Wang T, Xiao XH, Li WH, Yuan T, Sun XF, Wang H. Fulminant type 1 diabetes: report of two cases. Chin Med J (Engl) 2008; 121(2): 181-182.
17. Zheng C, Zhou Z, Yang L, et al. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese. Diabetes Metab Res Rev 2011; 27(1): 70-78.
18. Tsutsumi C, Imagawa A, Ikegami H, Makino H, Kobayashi T, Hanfusa T, The Research Committee of Type 1 Diabetes in the Japan Diabetes. Class II HLA genotype in fulminant type 1 diabetes. Diabetes 2009; 58(Suppl. 1): A299.
19. Imagawa A, Hanafusa T, Uchigata Y, et al. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 2005; 48(2): 294-300. Erratum in: Diabetologia 2008; 51(3): 524-526.
20. Kawasaki E, Imagawa A, Makino H, et al. Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care 2008; 31(8): 1608-1610.
21. Kawabata Y, Ikegami H, Awata T, et al. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 2009; 52(12): 2513-2521.
22. Imagawa A, Hanafusa T, Makino H, Miyagawa JI, Juto P. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia 2005; 48(2): 290-293.
23. Sekine N, Motokura T, Oki T, et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 2001; 285(9): 1153-1154.
24. Sano H, Terasaki J, Tsutsumi C, Imagawa A, Hanafusa T. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res Clin Pract 2008; 79(3): e8-e9.
25. Goto A, Takahashi Y, Kishimoto M, et al. A case of fulminant type 1 diabetes associated with significant elevation of mumps titers. Endocr J 2008; 55(3): 561-564.
26. Akatsuka H, Yano Y, Gabazza EC, et al. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diabetes Res Clin Pract 2009; 84(3): e50-e52.
27. Hwang YC, Jeong IK, Chon S, et al. Fulminant type 1 diabetes mellitus associated with acute hepatitis A. Diabet Med 2010; 27(3): 366-367.
28. Hanafusa T, Imagawa A, Iwahashi H, et al. Report of the Japan Diabetes Society's Committee on research on fulminant type 1 diabetes mellitus: analysis of antiviral antibodies at disease onset. J Japan Diab Soc 2008; 51(6): 531-536 (Japanese).
29. Shibasaki S, Imagawa A, Tauriainen S, et al. Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. Endocr J 2010; 57(3): 211-219.
30. Tanaka S, Nishida Y, Aida K, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes 2009; 58(10): 2285-2291.
31. Haseda F, Murasa-Mishiba Y, Hirano-Kuwata S, Jungo T, Imagawa A, Hanfusa T. Reduced expression of intracellular CTLA-4 in regulatory T cells from patients with fulminant type 1 diabetes. Diabetes 2010; 59(Suppl. 1): A362.
32. Seino Y, Nanjo K, Tajima N, et al. (2010) Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Journal of Diabetes Investigation 2010; 1(5): 212-228.